Welcome to Tuesday's Overnight Health Care. Senators who spent the day answering questions on Brett Kavanaugh will get some relief the rest of this week. After passing the "minibus" $854 billion spending bill, which includes funding for the Department of Health and Human Services, the Senate announced no more votes until next week.

There is at least some bipartisanship going on in the Senate, on a problem that doesn't always get a lot of attention.

ADVERTISEMENT

A bipartisan group is unveiling a draft measure to crack down on surprise medical bills, which they say have plagued patients with massive unexpected charges for care.

What does it do?

Prevent a health care provider that is outside of a patient's insurance network from charging additional costs for emergency services to patients beyond the amount usually allowed under their insurance plan.

Require health care providers to give written notification to patients who receive emergency care at an out-of-network facility before they receive any follow-up nonemergency care.

Patients also could not be charged more for care from out-of-network doctors at an in-network hospital (for example, an anesthesiologist).

Why is it needed? The lawmakers point to examples like one that received a flood of national attention last month, when NPR and Kaiser Health News reported on a high school teacher who was charged $109,000 by the hospital that cared for his heart attack, even after his insurance had already paid $56,000.

Drug pricing advocates are trying to stop one of Pharma's top priorities from getting through Congress with new ads.

The ads from Patients for Affordable Drugs Now seek to counteract an aggressive lobbying push by drug companies to undo a change from February that shifted billions of dollars in new costs onto them.

"Big Pharma's trying to cut a backroom deal in Washington, forcing seniors to pay more, so drug companies can make more," the ad states. "If they get away with it, it'll mean a $4 billion windfall for them, and even higher drug prices for you."

What's the provision? At issue is a change Congress made in February as part of a budget deal that shifted more costs in a gap in Medicare coverage known as the "donut hole" onto drug companies.

Ever since, drug companies have been scrambling to undo the change.

What could be in the deal: As part of the dealmaking, one possibility is that a measure aimed at lowering drug prices, known as the Creates Act, could be included as something of a trade in exchange for easing the burden on drug companies from the February provision.

"This new legislation represents a thoughtful, bipartisan solution that will expand access to treatment while targeting the cost, and we will push for its inclusion in the final House-Senate opioid package," Portman said in a statement.

Why it matters: Current law bans the use of Medicaid funds for inpatient treatment centers with more than 16 beds. This was passed as part of Medicaid in 1965 and aimed at preventing the warehousing of mentally ill people in large institutions. But advocates say the restrictions are now outdated because of changes in how people with substance use disorders are treated.

What's next: A partial repeal of the restriction was included in the House-passed opioids package, but now in the Senate's. Now Portman is pushing for his proposal to be included in the final bill that comes out of the conference between the two houses.

Lawmakers heard from health industry officials on efforts to increase transparency in pricing and care quality during a Tuesday hearing before the Senate health committee, The Hill's James Wellemeyer reports.